Cyclophosphamide for severe lupus nephritis: where are we now?
Mok
Chi Chiu
CC
D002985:Clinical Protocols; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004333:Drug Administration Routes; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008181:Lupus Nephritis / Q000188:drug therapy*; D012107:Research Design
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide